Register
Login:
Share:
Email Facebook Twitter

RNS VIDEO: Reabold Resources #RBD raise £6 million and take stake in Danube Petroleum Watch here

EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential


Hemogenyx Share Price (HEMO)



Share Price Information for Hemogenyx (HEMO)


Share Price: 2.625Bid: 2.50Ask: 2.75Change: 0.00 (0.00%)No Movement on Hemogenyx
Spread: 0.25Spread as %: 10.00%Open: 2.625High: 2.625Low: 2.625Yesterday’s Close: 2.625

Hemogenyx Pharmaceuticals Plc Ord Gbp0.01

Hemogenyx is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
2.625

Share Price SpacerBid
2.50

Share Price SpacerAsk
2.75

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
207,366

Share Price SpacerOpen
2.625

Share Price SpacerHigh
2.625

Share Price SpacerLow
2.625

Share Price SpacerClose
2.625

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 356.04m £9.35m 30,000

52 Week High 3.25 52 Week High Date 20-NOV-2017
52 Week Low 2.25 52 Week Low Date 5-DEC-2017

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
7 207,366 0 -3.281 -0.80 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

12-Dec-17
15:17:39
2.575
7,284
Sell* 
2.50
2.75
187.56
Trade Type:
Ordinary

12-Dec-17
14:31:48
2.50
24,478
Sell* 
2.50
2.75
611.95
Trade Type:
Ordinary

12-Dec-17
13:24:19
2.6125
84,353
Sell* 
2.50
2.75
2,204
Trade Type:
Ordinary




View more Hemogenyx trades >>

Directors Deals for Hemogenyx (HEMO)
Trade DateActionNotifierPriceCurrencyAmountHolding
06-Oct-17Buy
Trade Notifier Information for Hemogenyx Pharmaceuticals
Adrian Beeston held the position of Non-Executive Director at Hemogenyx Pharmaceuticals at the time of this trade.
 Adrian Beeston
3.1GBX10,0005424286
06-Oct-17Buy
Trade Notifier Information for Hemogenyx Pharmaceuticals
Peter Redmond held the position of Non-Executive Director at Hemogenyx Pharmaceuticals at the time of this trade.
 Peter Redmond
3.14GBX155,0005040714
06-Oct-17Buy
Trade Notifier Information for Hemogenyx Pharmaceuticals
Adrian Beeston held the position of Non-Executive Director at Hemogenyx Pharmaceuticals at the time of this trade.
 Adrian Beeston
2.96GBX400,0006131969
View more Hemogenyx directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Today 22:22Newtoallthis2015Twitter2.625No Opinion
WOW.. Check the links to the major shareholders its on twitter search #HEMO. This is going to be an absolute monster
Mon 23:37YTSSRE: podcast2.625No Opinion
Cannot open the link. What does it say
.
Mon 18:41russtypodcast2.625No Opinion
https://twitter.comstatus/940221661785280512
"We know our technology works"
Fri 21:13Serendipity888RE: Tip/Oxford2.45No Opinion
Lake Phsrma and Oxford uni .. certainly giving us the backup / expertese we need
Thu 08:12ShukanRE: Tip/Oxford2.50Strong Buy
LakePharma, the largest US-based biologics contract research organisation, brings integrated antibody engineering and bioproduction expertise to allow Hemogenyx to advance its CDX product through the necessary preclinical stages to potentially be ready to enter the clinic within 16 months. To date, work is progressing successfully toward the Company's immediate goal of submitting an IND application to the US Food and Drug Administration. 
Thu 07:22FeverCluckerRNS - Lakepharma on board2.375Strong Buy
Now we can expect some fun.....

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Hemogenyx (HEMO) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.